These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine. Haas S, Stemberger A, Fritsche HM, Welzel D, Wolf H, Lechner F, Blümel G. Arzneimittelforschung; 1987 Jul; 37(7):839-43. PubMed ID: 2823840 [Abstract] [Full Text] [Related]
18. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective. Hull RD, Raskob GE, Pineo GF, Feldstein W, Rosenbloom D, Gafni A, Green D, Feinglass J, Trowbridge AA, Elliott CG. Arch Intern Med; 1997 Feb 10; 157(3):298-303. PubMed ID: 9040296 [Abstract] [Full Text] [Related]
19. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke. Sandset PM, Dahl T, Stiris M, Rostad B, Scheel B, Abildgaard U. Semin Thromb Hemost; 1990 Oct 10; 16 Suppl():25-33. PubMed ID: 1962901 [Abstract] [Full Text] [Related]